Reply: NDM-producing Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Korea: A Growing Threat Requiring National Attention. [PDF]
Kim T, Chong YP.
europepmc +1 more source
<i>In vivo</i> selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing <i>E. coli</i> ST410. [PDF]
Jousset AB +10 more
europepmc +1 more source
Treatment Bundle for Bloodstream Infection Caused by Carbapenem-Resistant <i>Klebsiella Pneumoniae</i> After Liver Transplantation: A Retrospective Cohort Study. [PDF]
Guo Z +9 more
europepmc +1 more source
Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations. [PDF]
Gatti M, Pea F.
europepmc +1 more source
NDM-producing Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Korea: A Growing Threat Requiring National Attention. [PDF]
Kim B.
europepmc +1 more source
Cluster analysis to define distinct clinical phenotypes among septic patients with bloodstream infections [PDF]
Bernauer, Michael +3 more
core +1 more source
Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance Database. [PDF]
Arseniu AM +10 more
europepmc +1 more source
The impact of ceftazidime-avibactam on 30-day mortality in the treatment of OXA-48 producing <i>Enterobacterales</i> infections: a systematic review and meta-analysis. [PDF]
Foo AL, Young B, Ng OT, Vasoo S.
europepmc +1 more source
Impact of loading dose β-lactam therapy on outcomes of KPC-producing Klebsiella pneumoniae bloodstream infections in non-ICU patients: a real world study. [PDF]
Frallonardo L +10 more
europepmc +1 more source

